AGENTS DE DEPLETION DE CELLULES-B, COMME LES ANTICORPS ANTI-CD20 OU LEURS FRAGMENTS, POUR LE TRAITEMENT DU SYNDROME DE FATIGUE CHRONIQUE

• 收藏
• 分享

专利权人:

BERGEN TEKNOLOGIOVERFORING AS

发明人:

MELLA, OLAV,FLUGE, ØYSTEIN

申请号：

CA2706899

公开号：

CA2706899C

申请日:

2009.01.02

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The present invention relates in a first aspect to a B-cell depleting anti-CD20 antibody or a CD20-binding antibodyfragment thereof for the treatment of chronic fatigue syndrome and myalgicencephalomyelitis. In particular, the present inventionrelates to the use of anti-CD20 monoclonal antibodies or fragments thereofwhich are preferably humanized for the treatment ofchronic fatigue syndrome/myalgic encephalomyelitis in a subject afflicted withsaid disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/